Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular lipids identify cardiovascular risk and are efficiently lowered by simvastatin and PCSK9 deficiency.

The Journal of clinical endocrinology and metabolism - 1 Jan 2014

Tarasov Kirill, Ekroos Kim, Suoniemi Matti, Kauhanen Dimple, Sylvänne Tuulia, Hurme Reini, Gouni-Berthold Ioanna, Berthold Heiner K, Kleber Marcus E, Laaksonen Reijo, März Winfried

Abstract excerpt

CONTEXT: Coronary artery disease (CAD) is among the leading causes of mortality and morbidity worldwide. Traditional risk markers explain only a proportion of total cardiovascular risk. Thus, development and improvement of early diagnostic strategies and targeted initiation of preventive measures would be of great benefit. OBJECTIVE: We aimed to identify molecular lipids that are associated with fatal outcome of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Azetidines
Share to Ezetimibe

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hypolipidemic Agents

Share to Macromolecular Substances

Share to Proprotein Convertase 9

Share to Proprotein Convertases

Share to Randomized Controlled Trials as Topic

Share to Simvastatin

Source

Open in PubMed Open full text

Identifiers

PMID: 24243630
DOI: 10.1210/jc.2013-2559
PMCID: PMC3928964

Genes

CAD
PCSK9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular lipids identify cardiovascular risk and are efficiently lowered by simvastatin and PCSK9 deficiency.PMID 24243630Read ↗

Circulating ceramides as biomarkers of cardiovascular disease: Evidence from phenotypic and genomic studiesSemantic proximity Read ↗

Genomics of lipid metabolism : identification of genetic determinants of lipid metabolites and the effect of perturbations of lipid levels on coronary heart disease risk factorsSemantic proximity Read ↗

Beyond LDL-C lowering: distinct molecular sphingolipids are good indicators of proprotein convertase subtilisin/kexin type 9 (PCSK9) deficiency.Semantic proximity Read ↗

Novel and future lipid-modulating therapies for the prevention of cardiovascular diseaseSemantic proximity Read ↗

Integrated omics approach for the identification of HDL structure-function relationships in PCSK9-related familial hypercholesterolemia.Semantic proximity Read ↗

Role of Ceramides in the Molecular Pathogenesis and Potential Therapeutic Strategies of Cardiometabolic Diseases: What we Know so FarSemantic proximity Read ↗

Effect of PCSK9 Inhibitors on Regulators of Lipoprotein Homeostasis, Inflammation and CoagulationSemantic proximity Read ↗

Ceramide Remodeling and Risk of Cardiovascular Events and MortalitySemantic proximity Read ↗

Plasma lipid composition and risk of developing cardiovascular disease.Semantic proximity Read ↗

Mid-Life Plasmalogens and Other Metabolites with Anti-Inflammatory Properties are Inversely Associated with Long term Cardiovascular Disease Events: Heart SCORE StudySemantic proximity Read ↗

An Unbiased Lipid Phenotyping Approach To Study the Genetic Determinants of Lipids and Their Association with Coronary Heart Disease Risk FactorsSemantic proximity Read ↗

HDL-associated phosphatidylserine blunts myeloid activation and protects from atherosclerosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.